医学资讯2型糖尿病GLP-1受体激动剂
GLP-1受体激动剂与糖尿病患者感觉异常:风险关联新证据
By MedXY|2026年8月17日
本研究提示,GLP-1受体激动剂治疗与2型糖尿病患者嗅觉和味觉障碍风险升高显著相关,强调在临床中加强相关不良反应认知与监测的重要性。
Our website uses essential cookies and, with your consent, additional cookies to measure performance and improve our services. Cookie Policy.
You can change your choice at any time.